MALAT1 and type 2 diabetes mellitus: lncRNA-MALAT1 has emerged as a promising biomarker for Dr A study involving 80 patients diagnosed with type 2 diabetes and 81 healthy individuals measured the expression levels of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1.